PRICE T ROWE ASSOCIATES INC /MD/
Position in ENTA — Enanta Pharmaceuticals Inc
CIK 80255
BALTIMORE, MD
Position in ENTA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$339,670
+$103,439 QoQ
Shares Held
23,297
+24.6% QoQ
Ownership
0.080%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 122 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ENTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. ENTA ranks #224 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | TWST |
Twist Bioscience Corp
|
3,634,652 | $373,932,997 |
All Filings in ENTA
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $339,670 | 23,297 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $236,231 | 18,704 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $227,245 | 14,410 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $121,447 | 10,146 | Shares | Defined | 2025-11-14 | |
| 2023-09-30 | $130,443 | 11,678 | Shares | Defined | 2023-11-14 | |
| 2023-03-31 | $6,579,344 | 162,694 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $8,108,574 | 174,303 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $12,484,434 | 240,687 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,902,973 | 188,343 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $13,741,939 | 193,059 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $20,513,425 | 274,317 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $14,891,207 | 262,123 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $11,124,935 | 252,782 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $42,625,352 | 864,261 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $40,476,834 | 961,445 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $44,609,359 | 974,429 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $64,397,186 | 1,282,557 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $69,684,461 | 1,354,938 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||